Intravitreal Bevacizumab in Nonarteritic Anterior Ischemic Optic Neuropathy

Ebadollah Heidari, Mohammad Reza Niyousha, Reza Heidari, Babak Rahimi-Aradabili, Farzad Hami Adl, Nooshin Bazzazi

Abstract


Purpose: To evaluate the effect of intravitreal injection of Bevacizumab on improving visual function in patients with Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). Methods: In a prospective interventional case series, 11 eyes with vision loss due to (NAION) in less than 15 days of attack were studied. Visual acuity, perimetry and optic nerve head changes were evaluated 1 week post-intravitreal injection of 1.25mg/0.1 mL Bevacizumab. Results: 5 of patients had improved visual acuity. In all patients optic disc edema resolved either completely or remarkably in 1 week, but there was no significant change in perimetric values. Conclusion: This case series suggest that intravitreal injection of Bevacizumab may be beneficial in treatment of NAION.


Keywords: Intravitreal Bevacizumab; Non-arteritic anterior ischemic optic neuropathy; Perimetry

 


Full Text:

PDF

References


Atkins EJ, Bruce BB, Newman NJ, et al. Treatment of nonarteritic anterior optic neuropathy. Surv Ophthalmol.2010;55:47-63

Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy

decompression trial follow-up study. Am J Ophthalmol. 2002;134(3):317-28

Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28:34-62

Kerr NM, Chew SS, Danesh-Meyer HV. Non-arteritic anterior ischaemic optic neuropathy: a review and update. J Clin Neurosci. 2009;16:994-1000

Arnold AC. In Miller NR, Newman NJ, Biousse V, et al (eds):Clinical Neuro-Ophthalmology, Ischemic optic neuropathy.vol. 1. Philadelphia, PA, Lippincott, Williams & Wilkins, ed 62005, pp. 349-84

Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies.Neurologist. 2008;14(6):341-54

Bennett JL, Thomas S, Olson JL, et al. Treatment of nonarteritic anterior ischemic optic neuropathy with

intravitreal bevacizumab. J Neuro-ophthalmol. 2007;27(3):238-40.

Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthalmol. 2003;23(2):157-63

Pepple KL, Bhatti MT, Foroozan R. Not again. Surv Ophthalmol. 2010.05.002

Johnson LN, Guy ME, Krohel GB, et al. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2000;107:521–6.

Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, et al. Lowdose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis ina rat ovarian hyperstimulation model. Endocrinology 2006;147:5400–11.


Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2019 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine